Us TB Disease Vaccine Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
TB Disease Vaccine Market was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030.
Exploring the Dynamics of the US Tuberculosis Vaccine Market Amidst Emerging Innovations
The United States tuberculosis (TB) vaccine market is undergoing significant transformation, driven by advancements in vaccine research, strategic collaborations, and a heightened focus on public health initiatives. Despite the relatively low incidence of TB in the U.S., the persistent global burden of the disease necessitates continuous efforts in vaccine development and distribution.
Market Overview
In 2023, North America accounted for approximately 34% of the global human tuberculosis vaccine market revenue, with the U.S. being a major contributor. The market is primarily segmented into two types:
Metal Intradermal Vaccines: Representing 60% of the market share, these vaccines are favored for their high efficacy and established use in TB immunization programs.
Percutaneous Vaccines: Comprising 40% of the market, this segment is experiencing rapid growth due to technological advancements and ease of administration.
Key Drivers
Several factors are propelling the growth of the TB vaccine market in the U.S.:
Innovative Research and Development: The emergence of new vaccine candidates, such as the M72/AS01E, which demonstrated approximately 50% efficacy in preventing active TB in clinical trials, showcases the potential for more effective immunization strategies.
Strategic Partnerships: Collaborations between pharmaceutical companies and non-profit organizations are accelerating vaccine development. For instance, the partnership between Biofabri and IAVI aims to advance the MTBVAC vaccine candidate, targeting both adolescents and adults.
Government Initiatives: The establishment of the Tuberculosis Vaccine Accelerator Council by the World Health Organization in January 2023 underscores a global commitment to expedite TB vaccine development and deployment.
Challenges
Despite these advancements, the market faces notable challenges:
High Development Costs: The financial investment required for vaccine research, clinical trials, and regulatory approvals is substantial, potentially hindering the entry of new market players.
Regulatory Hurdles: Navigating the complex regulatory landscape to achieve vaccine approval demands rigorous testing and compliance, which can be time-consuming and resource-intensive.
Vaccine Hesitancy: Public skepticism towards vaccinations, fueled by misinformation, poses a significant barrier to achieving widespread immunization coverage.
Future Outlook
The U.S. TB vaccine market is poised for growth, supported by ongoing research, strategic alliances, and proactive public health policies. The focus is on developing vaccines with higher efficacy, ensuring accessibility, and enhancing public awareness to combat tuberculosis effectively. As new vaccine candidates progress through clinical trials and receive regulatory approvals, the market is expected to expand, contributing to global efforts in reducing TB incidence and mortality.
Get an In-Depth Research Analysis of the Global TB Disease Vaccine Market Size And Forecast [2025-2032]
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC
Queen Saovabha Mem. Inst
Microgen
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global TB Disease Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global TB Disease Vaccine Market
Live Attenuated Vaccines
Recombinant Vaccines
Inactivated Vaccines
Synthetic Peptide Vaccines
DNA Vaccines
Intramuscular
Subcutaneous
Oral
Intranasal
Adults
Children
High-risk Groups (including immunocompromised individuals)
Elderly
Preventive Vaccination
Therapeutic Vaccination
Hospitals
Clinics
Pharmacies
Online Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ TB Disease Vaccine Market Research Analysis
1. Introduction of the Global TB Disease Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global TB Disease Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global TB Disease Vaccine Market, By Type
6. Global TB Disease Vaccine Market, By Application
7. Global TB Disease Vaccine Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global TB Disease Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/